Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.120 +0.050 (+1.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

23 24 Next >

2 Under-the-Radar Stocks With Incredible Upside Potential ↗

January 28, 2024

It's also important to consider their downsides.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week ↗

January 25, 2024

The widely followed growth stock investor is adding to some of her holdings this week.

Via The Motley Fool

Altitude Lab Startups Raise Over $120M in Capital

January 24, 2024

Launches Fellowship Grant Opportunity for Early Career Entrepreneurs

From Recursion Pharmaceuticals

Via GlobeNewswire

Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares ↗

January 17, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Recursion Pharmaceuticals Through 4 Analysts ↗

January 17, 2024

Via Benzinga

What's Going On With Recursion Pharmaceuticals Stock? ↗

January 09, 2024

Via Benzinga

Peering Into Recursion Pharmaceuticals's Recent Short Interest ↗

January 01, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 15, 2024

Via Benzinga

3 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

January 15, 2024

These companies are still in the early innings of their growth potential.

Via The Motley Fool

Missed the Boat on Nvidia? Here Are 2 Artificial Intelligence (AI) Growth Stocks Using Nvidia's Tech to Reach New Heights ↗

January 13, 2024

Nvidia provides artificial intelligence solutions for various markets, including the healthcare and automotive industries.

Via The Motley Fool

Topics Artificial Intelligence

Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week ↗

January 13, 2024

These companies could stand out thanks to game-changing technology.

Via The Motley Fool

Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock ↗

January 09, 2024

Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.

Via InvestorPlace

2 Cathie Wood Stocks That Might Be Smart Buys Right Now ↗

December 17, 2023

These two biotech stocks hold enormous potential.

Via The Motley Fool

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday ↗

January 09, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Via Benzinga

Topics Stocks

Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference

January 08, 2024

Recursion and NVIDIA will host an invite-only event on Wednesday, January 10, where Recursion will provide live demonstrations of LOWE, its new LLM-based software that can perform complex drug...

From Recursion Pharmaceuticals

Via GlobeNewswire

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗

January 04, 2024

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...

Via Benzinga

Topics Stocks

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

January 04, 2024

Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024 ↗

January 03, 2024

The widely followed aggressive growth investor is adding to some of her holdings as she kicks off the new year.

Via The Motley Fool

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

January 03, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock ↗

January 02, 2024

Via Benzinga

3 Biotech Stocks at the Forefront of the Quest for Eternal Youth ↗

January 02, 2024

Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.

Via InvestorPlace

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Via Talk Markets

Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher ↗

December 26, 2023

On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before.

Via Investor's Business Daily

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

December 20, 2023

Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets.

From Recursion Pharmaceuticals

Via GlobeNewswire

3 Genomics Stocks to Unlock the Future of Medicine ↗

December 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

Via InvestorPlace

These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest? ↗

December 18, 2023

2024 is going to be a sizzler in the biopharma sector.

Via The Motley Fool

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗

December 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Via InvestorPlace

Topics Artificial Intelligence

Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock ↗

December 14, 2023

Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies.

Via InvestorPlace

Topics Artificial Intelligence

These 9 Micro/Small Cap AI Stocks Continue In Bubble Mode ↗

December 12, 2023

9 micro/small cap AI stocks are still in bubble mode advancing 14.8%, on average, last week. In comparison, the Global X Artificial Intelligence & Technology ETF was only up 0.5% and the iShares...

Via Talk Markets

Topics Artificial Intelligence ETFs

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.